SEC Form 4 · accession 0001209191-15-040045
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laurence James Neil Cooper
Officer — Chief Executive Officer
Period of report
May 5, 2015
Accepted (ET)
May 7, 2015 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 5, 2015 | A | 1,000,000 | $0.00 | A | 1,000,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1333,334 shares shall vest on 5/5/2016; 333,333 shares shall vest on each of 5/5/2017 and 5/5/2018